AMENDMENT #1 TO THE CLINICAL STUDY AGREEMENTClinical Study Agreement • July 1st, 2014
Contract Type FiledJuly 1st, 2014This amendment (the “Amendment”) to the Clinical Study Agreement, dated 09 September 2013 (the “Agreement”), for the clinical study conducted in accordance with the protocol PROUD-PV „A randomized, open-label, multicenter, controlled, parallel arm, phase III study assessing the efficacy and safety of AOP2014 vs. Hydroxyurea in patients with Polycythemia Vera” and any amendments thereto (the “Study”), is made by and between: